HEADER TRANSFERASE (AMINOTRANSFERASE) 23-AUG-95 1ARH TITLE ASPARTATE AMINOTRANSFERASE, Y225R/R386A MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: ASPARTATE AMINOTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ASPARTATE TRANSAMINASE; COMPND 5 EC: 2.6.1.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: 600 TIMES INCREASED BETA-DECARBOXYLASE ACTIVITY SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 STRAIN: TY103; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: TY103; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PKDHE19 KEYWDS TRANSFERASE (AMINOTRANSFERASE) EXPDTA X-RAY DIFFRACTION AUTHOR V.N.MALASHKEVICH,J.N.JANSONIUS REVDAT 6 07-FEB-24 1ARH 1 REMARK REVDAT 5 03-NOV-21 1ARH 1 REMARK SEQADV REVDAT 4 18-APR-18 1ARH 1 REMARK REVDAT 3 24-FEB-09 1ARH 1 VERSN REVDAT 2 01-APR-03 1ARH 1 JRNL REVDAT 1 14-NOV-95 1ARH 0 JRNL AUTH R.GRABER,P.KASPER,V.N.MALASHKEVICH,E.SANDMEIER,P.BERGER, JRNL AUTH 2 H.GEHRING,J.N.JANSONIUS,P.CHRISTEN JRNL TITL CHANGING THE REACTION SPECIFICITY OF A JRNL TITL 2 PYRIDOXAL-5'-PHOSPHATE-DEPENDENT ENZYME. JRNL REF EUR.J.BIOCHEM. V. 232 686 1995 JRNL REFN ISSN 0014-2956 JRNL PMID 7556224 JRNL DOI 10.1111/J.1432-1033.1995.TB20861.X REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT 4C REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 43040 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6124 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 371 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : 35.300 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.010 ; 0.020 ; 6306 REMARK 3 BOND ANGLES (DEGREES) : 2.060 ; 3.000 ; 8512 REMARK 3 TORSION ANGLES (DEGREES) : 25.000; 15.000; 3758 REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : 0.007 ; 0.020 ; 178 REMARK 3 GENERAL PLANES (A) : 0.011 ; 0.020 ; 918 REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : 3.200 ; 0.200 ; 6544 REMARK 3 NON-BONDED CONTACTS (A) : 0.017 ; 0.100 ; 23 REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : MOEWS AND KRETSINGER, JMB (1975) 91,201-22 REMARK 3 KSOL : 0.73 REMARK 3 BSOL : 253.9 REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : ENGH AND HUBER REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : B-CORRELATION METHOD REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1ARH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171167. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-OCT-93 REMARK 200 TEMPERATURE (KELVIN) : 277 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : DIFFRACTOMETER REMARK 200 DETECTOR MANUFACTURER : ENRAF-NONIUS FAST REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MADNES REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.80500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: MTRIX REMARK 300 THE TRANSFORMATIONS PRESENTED ON MTRIX RECORDS BELOW REMARK 300 DESCRIBE NON-CRYSTALLOGRAPHIC RELATIONSHIPS AMONG THE REMARK 300 VARIOUS DOMAINS IN THIS ENTRY. APPLYING THE APPROPRIATE REMARK 300 MTRIX TRANSFORMATION TO THE RESIDUES LISTED FIRST WILL REMARK 300 YIELD APPROXIMATE COORDINATES FOR THE RESIDUES LISTED REMARK 300 SECOND. REMARK 300 REMARK 300 APPLIED TO TRANSFORMED TO REMARK 300 MTRIX RESIDUES RESIDUES RMSD REMARK 300 M1 A 5 .. A 409 B 5 .. B 409 0.280 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN B 331 O HOH B 571 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 43 CD GLU A 43 OE1 0.069 REMARK 500 GLU A 62 CD GLU A 62 OE2 0.066 REMARK 500 GLU A 85 CD GLU A 85 OE1 0.067 REMARK 500 GLU A 164 CD GLU A 164 OE2 0.067 REMARK 500 GLU A 179 CD GLU A 179 OE2 0.072 REMARK 500 GLU A 235 CD GLU A 235 OE1 0.076 REMARK 500 GLU A 320 CD GLU A 320 OE2 0.070 REMARK 500 GLU B 62 CD GLU B 62 OE2 0.068 REMARK 500 GLU B 85 CD GLU B 85 OE1 0.067 REMARK 500 GLU B 214 CD GLU B 214 OE2 0.068 REMARK 500 GLU B 234 CD GLU B 234 OE2 0.066 REMARK 500 GLU B 278 CD GLU B 278 OE2 0.069 REMARK 500 GLU B 320 CD GLU B 320 OE1 0.070 REMARK 500 GLU B 402 CD GLU B 402 OE2 0.066 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 22 CB - CG - OD1 ANGL. DEV. = -6.1 DEGREES REMARK 500 ASP A 22 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ARG A 29 NE - CZ - NH1 ANGL. DEV. = 4.4 DEGREES REMARK 500 ASP A 117 CB - CG - OD1 ANGL. DEV. = -5.7 DEGREES REMARK 500 ASP A 169 CB - CG - OD1 ANGL. DEV. = 6.9 DEGREES REMARK 500 ASP A 169 CB - CG - OD2 ANGL. DEV. = -6.8 DEGREES REMARK 500 ASP A 184 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP A 236 CB - CG - OD1 ANGL. DEV. = -6.3 DEGREES REMARK 500 ASP A 236 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 GLU A 376 CB - CA - C ANGL. DEV. = -15.6 DEGREES REMARK 500 PHE A 377 CB - CG - CD2 ANGL. DEV. = -5.3 DEGREES REMARK 500 ASP B 15 CB - CG - OD1 ANGL. DEV. = 6.4 DEGREES REMARK 500 ASP B 15 CB - CG - OD2 ANGL. DEV. = -6.9 DEGREES REMARK 500 ASP B 22 CB - CG - OD1 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP B 22 CB - CG - OD2 ANGL. DEV. = -6.0 DEGREES REMARK 500 ASP B 27 CB - CG - OD1 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP B 42 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP B 42 CB - CG - OD2 ANGL. DEV. = -7.1 DEGREES REMARK 500 ASP B 162 CB - CG - OD1 ANGL. DEV. = 6.2 DEGREES REMARK 500 ASP B 169 CB - CG - OD2 ANGL. DEV. = -6.4 DEGREES REMARK 500 ASP B 171 CB - CG - OD1 ANGL. DEV. = -6.6 DEGREES REMARK 500 ASP B 184 CB - CG - OD1 ANGL. DEV. = -7.3 DEGREES REMARK 500 ASP B 184 CB - CG - OD2 ANGL. DEV. = 6.1 DEGREES REMARK 500 ASP B 236 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 ASP B 313 CB - CG - OD2 ANGL. DEV. = -5.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 30 -86.46 -39.80 REMARK 500 ILE A 37 127.48 -171.65 REMARK 500 GLU A 43 -19.29 -45.41 REMARK 500 TYR A 160 -55.94 -145.29 REMARK 500 ALA A 229 -74.65 -85.52 REMARK 500 ARG A 266 64.63 68.53 REMARK 500 ASN A 294 -83.81 -104.60 REMARK 500 SER A 296 -64.00 87.04 REMARK 500 GLU A 343 -4.36 -58.45 REMARK 500 LEU A 365 153.95 -45.52 REMARK 500 ALA A 407 -6.26 -54.90 REMARK 500 GLU B 7 -39.28 -36.66 REMARK 500 ILE B 17 -60.89 -92.47 REMARK 500 ALA B 26 41.01 -99.17 REMARK 500 GLU B 28 62.11 -103.36 REMARK 500 PRO B 30 -100.65 -47.21 REMARK 500 TYR B 70 142.08 -39.18 REMARK 500 TYR B 160 -47.61 -148.97 REMARK 500 ALA B 229 -69.91 -97.95 REMARK 500 MET B 246 18.82 -150.90 REMARK 500 TYR B 263 -50.31 -27.28 REMARK 500 ARG B 266 68.84 64.99 REMARK 500 ASN B 294 -79.84 -104.03 REMARK 500 SER B 296 -59.45 81.70 REMARK 500 HIS B 301 -71.46 -39.14 REMARK 500 LYS B 344 -5.84 -44.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: ACT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NULL REMARK 800 REMARK 800 SITE_IDENTIFIER: BCT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NULL REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PPD A 411 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PPD B 411 DBREF 1ARH A 5 409 UNP P00509 AAT_ECOLI 1 396 DBREF 1ARH B 5 409 UNP P00509 AAT_ECOLI 1 396 SEQADV 1ARH ARG A 225 UNP P00509 TYR 214 ENGINEERED MUTATION SEQADV 1ARH ALA A 386 UNP P00509 ARG 374 ENGINEERED MUTATION SEQADV 1ARH ARG B 225 UNP P00509 TYR 214 ENGINEERED MUTATION SEQADV 1ARH ALA B 386 UNP P00509 ARG 374 ENGINEERED MUTATION SEQRES 1 A 396 MET PHE GLU ASN ILE THR ALA ALA PRO ALA ASP PRO ILE SEQRES 2 A 396 LEU GLY LEU ALA ASP LEU PHE ARG ALA ASP GLU ARG PRO SEQRES 3 A 396 GLY LYS ILE ASN LEU GLY ILE GLY VAL TYR LYS ASP GLU SEQRES 4 A 396 THR GLY LYS THR PRO VAL LEU THR SER VAL LYS LYS ALA SEQRES 5 A 396 GLU GLN TYR LEU LEU GLU ASN GLU THR THR LYS ASN TYR SEQRES 6 A 396 LEU GLY ILE ASP GLY ILE PRO GLU PHE GLY ARG CYS THR SEQRES 7 A 396 GLN GLU LEU LEU PHE GLY LYS GLY SER ALA LEU ILE ASN SEQRES 8 A 396 ASP LYS ARG ALA ARG THR ALA GLN THR PRO GLY GLY THR SEQRES 9 A 396 GLY ALA LEU ARG VAL ALA ALA ASP PHE LEU ALA LYS ASN SEQRES 10 A 396 THR SER VAL LYS ARG VAL TRP VAL SER ASN PRO SER TRP SEQRES 11 A 396 PRO ASN HIS LYS SER VAL PHE ASN SER ALA GLY LEU GLU SEQRES 12 A 396 VAL ARG GLU TYR ALA TYR TYR ASP ALA GLU ASN HIS THR SEQRES 13 A 396 LEU ASP PHE ASP ALA LEU ILE ASN SER LEU ASN GLU ALA SEQRES 14 A 396 GLN ALA GLY ASP VAL VAL LEU PHE HIS GLY CYS CYS HIS SEQRES 15 A 396 ASN PRO THR GLY ILE ASP PRO THR LEU GLU GLN TRP GLN SEQRES 16 A 396 THR LEU ALA GLN LEU SER VAL GLU LYS GLY TRP LEU PRO SEQRES 17 A 396 LEU PHE ASP PHE ALA ARG GLN GLY PHE ALA ARG GLY LEU SEQRES 18 A 396 GLU GLU ASP ALA GLU GLY LEU ARG ALA PHE ALA ALA MET SEQRES 19 A 396 HIS LYS GLU LEU ILE VAL ALA SER SER TYR SER LYS ASN SEQRES 20 A 396 PHE GLY LEU TYR ASN GLU ARG VAL GLY ALA CYS THR LEU SEQRES 21 A 396 VAL ALA ALA ASP SER GLU THR VAL ASP ARG ALA PHE SER SEQRES 22 A 396 GLN MET LYS ALA ALA ILE ARG ALA ASN TYR SER ASN PRO SEQRES 23 A 396 PRO ALA HIS GLY ALA SER VAL VAL ALA THR ILE LEU SER SEQRES 24 A 396 ASN ASP ALA LEU ARG ALA ILE TRP GLU GLN GLU LEU THR SEQRES 25 A 396 ASP MET ARG GLN ARG ILE GLN ARG MET ARG GLN LEU PHE SEQRES 26 A 396 VAL ASN THR LEU GLN GLU LYS GLY ALA ASN ARG ASP PHE SEQRES 27 A 396 SER PHE ILE ILE LYS GLN ASN GLY MET PHE SER PHE SER SEQRES 28 A 396 GLY LEU THR LYS GLU GLN VAL LEU ARG LEU ARG GLU GLU SEQRES 29 A 396 PHE GLY VAL TYR ALA VAL ALA SER GLY ALA VAL ASN VAL SEQRES 30 A 396 ALA GLY MET THR PRO ASP ASN MET ALA PRO LEU CYS GLU SEQRES 31 A 396 ALA ILE VAL ALA VAL LEU SEQRES 1 B 396 MET PHE GLU ASN ILE THR ALA ALA PRO ALA ASP PRO ILE SEQRES 2 B 396 LEU GLY LEU ALA ASP LEU PHE ARG ALA ASP GLU ARG PRO SEQRES 3 B 396 GLY LYS ILE ASN LEU GLY ILE GLY VAL TYR LYS ASP GLU SEQRES 4 B 396 THR GLY LYS THR PRO VAL LEU THR SER VAL LYS LYS ALA SEQRES 5 B 396 GLU GLN TYR LEU LEU GLU ASN GLU THR THR LYS ASN TYR SEQRES 6 B 396 LEU GLY ILE ASP GLY ILE PRO GLU PHE GLY ARG CYS THR SEQRES 7 B 396 GLN GLU LEU LEU PHE GLY LYS GLY SER ALA LEU ILE ASN SEQRES 8 B 396 ASP LYS ARG ALA ARG THR ALA GLN THR PRO GLY GLY THR SEQRES 9 B 396 GLY ALA LEU ARG VAL ALA ALA ASP PHE LEU ALA LYS ASN SEQRES 10 B 396 THR SER VAL LYS ARG VAL TRP VAL SER ASN PRO SER TRP SEQRES 11 B 396 PRO ASN HIS LYS SER VAL PHE ASN SER ALA GLY LEU GLU SEQRES 12 B 396 VAL ARG GLU TYR ALA TYR TYR ASP ALA GLU ASN HIS THR SEQRES 13 B 396 LEU ASP PHE ASP ALA LEU ILE ASN SER LEU ASN GLU ALA SEQRES 14 B 396 GLN ALA GLY ASP VAL VAL LEU PHE HIS GLY CYS CYS HIS SEQRES 15 B 396 ASN PRO THR GLY ILE ASP PRO THR LEU GLU GLN TRP GLN SEQRES 16 B 396 THR LEU ALA GLN LEU SER VAL GLU LYS GLY TRP LEU PRO SEQRES 17 B 396 LEU PHE ASP PHE ALA ARG GLN GLY PHE ALA ARG GLY LEU SEQRES 18 B 396 GLU GLU ASP ALA GLU GLY LEU ARG ALA PHE ALA ALA MET SEQRES 19 B 396 HIS LYS GLU LEU ILE VAL ALA SER SER TYR SER LYS ASN SEQRES 20 B 396 PHE GLY LEU TYR ASN GLU ARG VAL GLY ALA CYS THR LEU SEQRES 21 B 396 VAL ALA ALA ASP SER GLU THR VAL ASP ARG ALA PHE SER SEQRES 22 B 396 GLN MET LYS ALA ALA ILE ARG ALA ASN TYR SER ASN PRO SEQRES 23 B 396 PRO ALA HIS GLY ALA SER VAL VAL ALA THR ILE LEU SER SEQRES 24 B 396 ASN ASP ALA LEU ARG ALA ILE TRP GLU GLN GLU LEU THR SEQRES 25 B 396 ASP MET ARG GLN ARG ILE GLN ARG MET ARG GLN LEU PHE SEQRES 26 B 396 VAL ASN THR LEU GLN GLU LYS GLY ALA ASN ARG ASP PHE SEQRES 27 B 396 SER PHE ILE ILE LYS GLN ASN GLY MET PHE SER PHE SER SEQRES 28 B 396 GLY LEU THR LYS GLU GLN VAL LEU ARG LEU ARG GLU GLU SEQRES 29 B 396 PHE GLY VAL TYR ALA VAL ALA SER GLY ALA VAL ASN VAL SEQRES 30 B 396 ALA GLY MET THR PRO ASP ASN MET ALA PRO LEU CYS GLU SEQRES 31 B 396 ALA ILE VAL ALA VAL LEU HET PPD A 411 24 HET PPD B 411 24 HETNAM PPD 2-[(3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4- HETNAM 2 PPD YLMETHYLENE)-AMINO]-SUCCINIC ACID HETSYN PPD PYRIDOXYL-ASPARTIC ACID-5-MONOPHOSPHATE FORMUL 3 PPD 2(C12 H17 N2 O9 P) FORMUL 5 HOH *371(H2 O) HELIX 1 1 LEU A 18 ALA A 26 1 9 HELIX 2 2 THR A 51 ASN A 63 1 13 HELIX 3 3 PRO A 77 PHE A 88 1 12 HELIX 4 4 ALA A 93 ASN A 96 1 4 HELIX 5 5 GLY A 107 ASN A 122 1 16 HELIX 6 6 PRO A 141 ALA A 150 5 10 HELIX 7 7 PHE A 170 GLU A 179 1 10 HELIX 8 8 LEU A 202 LYS A 215 1 14 HELIX 9 9 GLU A 235 MET A 246 5 12 HELIX 10 10 TYR A 263 GLU A 265 5 3 HELIX 11 11 SER A 277 ARG A 292 1 16 HELIX 12 12 ALA A 300 SER A 311 1 12 HELIX 13 13 ASP A 313 LYS A 344 1 32 HELIX 14 14 SER A 351 LYS A 355 5 5 HELIX 15 15 LYS A 367 GLU A 375 1 9 HELIX 16 16 VAL A 389 GLY A 391 5 3 HELIX 17 17 MET A 397 VAL A 408 1 11 HELIX 18 18 LEU B 18 ARG B 25 1 8 HELIX 19 19 THR B 51 ASN B 63 1 13 HELIX 20 20 PRO B 77 PHE B 88 1 12 HELIX 21 21 ALA B 93 ASN B 96 1 4 HELIX 22 22 GLY B 107 ASN B 122 1 16 HELIX 23 23 ASN B 142 ALA B 150 1 9 HELIX 24 24 PHE B 170 GLU B 179 1 10 HELIX 25 25 LEU B 202 LYS B 215 1 14 HELIX 26 26 LEU B 233 ALA B 244 1 12 HELIX 27 27 SER B 277 ARG B 292 1 16 HELIX 28 28 ALA B 300 SER B 311 1 12 HELIX 29 29 ASP B 313 GLU B 343 1 31 HELIX 30 30 SER B 351 LYS B 355 5 5 HELIX 31 31 LYS B 367 GLU B 375 1 9 HELIX 32 32 VAL B 389 GLY B 391 5 3 HELIX 33 33 PRO B 394 ALA B 407 1 13 SHEET 1 A 5 ALA A 100 PRO A 106 0 SHEET 2 A 5 VAL A 267 VAL A 273 -1 N LEU A 272 O ARG A 101 SHEET 3 A 5 LEU A 250 SER A 255 -1 N SER A 254 O ALA A 269 SHEET 4 A 5 LEU A 218 PHE A 223 1 N PHE A 221 O ILE A 251 SHEET 5 A 5 VAL A 185 HIS A 189 1 N VAL A 186 O LEU A 218 SHEET 1 B 2 ARG A 129 ASN A 137 0 SHEET 2 B 2 GLU A 154 ALA A 159 1 N GLU A 154 O VAL A 133 SHEET 1 C 2 PHE A 360 PHE A 362 0 SHEET 2 C 2 ALA A 386 ASN A 388 -1 N VAL A 387 O SER A 361 SHEET 1 D 5 ALA B 100 PRO B 106 0 SHEET 2 D 5 VAL B 267 VAL B 273 -1 N LEU B 272 O ARG B 101 SHEET 3 D 5 LEU B 250 SER B 255 -1 N SER B 254 O ALA B 269 SHEET 4 D 5 LEU B 218 PHE B 223 1 N PRO B 219 O ILE B 251 SHEET 5 D 5 VAL B 185 HIS B 189 1 N VAL B 186 O LEU B 218 SHEET 1 E 2 ARG B 129 ASN B 137 0 SHEET 2 E 2 GLU B 154 ALA B 159 1 N GLU B 154 O VAL B 133 SHEET 1 F 2 PHE B 360 PHE B 362 0 SHEET 2 F 2 ALA B 386 ASN B 388 -1 N VAL B 387 O SER B 361 CISPEP 1 ASN A 137 PRO A 138 0 1.83 CISPEP 2 ASN A 194 PRO A 195 0 11.82 CISPEP 3 ASN B 137 PRO B 138 0 4.30 CISPEP 4 ASN B 194 PRO B 195 0 11.43 SITE 1 ACT 24 ASP A 15 ILE A 17 LEU A 18 ILE A 37 SITE 2 ACT 24 GLY A 38 VAL A 39 TYR B 70 GLY A 107 SITE 3 ACT 24 GLY A 108 THR A 109 TRP A 140 ASN A 194 SITE 4 ACT 24 ASP A 222 ALA A 224 ARG A 225 SER A 255 SITE 5 ACT 24 LYS A 258 ARG A 266 ARG B 292 SER B 296 SITE 6 ACT 24 ASN B 297 PHE A 360 ALA A 386 PPD A 411 SITE 1 BCT 24 ASP B 15 ILE B 17 LEU B 18 ILE B 37 SITE 2 BCT 24 GLY B 38 VAL B 39 TYR A 70 GLY B 107 SITE 3 BCT 24 GLY B 108 THR B 109 TRP B 140 ASN B 194 SITE 4 BCT 24 ASP B 222 ALA B 224 ARG B 225 SER B 255 SITE 5 BCT 24 LYS B 258 ARG B 266 ARG A 292 SER A 296 SITE 6 BCT 24 ASN A 297 PHE B 360 ALA B 386 PPD B 411 SITE 1 AC1 17 ILE A 37 GLY A 38 GLY A 108 THR A 109 SITE 2 AC1 17 TRP A 140 ASN A 194 ASP A 222 ARG A 225 SITE 3 AC1 17 SER A 255 SER A 257 LYS A 258 ARG A 266 SITE 4 AC1 17 PHE A 360 HOH A 443 TYR B 70 ARG B 292 SITE 5 AC1 17 HOH B 413 SITE 1 AC2 18 TYR A 70 ARG A 292 ILE B 17 GLY B 38 SITE 2 AC2 18 GLY B 108 THR B 109 TRP B 140 ASN B 194 SITE 3 AC2 18 ASP B 222 ARG B 225 SER B 255 SER B 257 SITE 4 AC2 18 LYS B 258 ARG B 266 PHE B 360 HOH B 424 SITE 5 AC2 18 HOH B 450 HOH B 590 CRYST1 84.120 79.610 89.850 90.00 117.91 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011888 0.000000 0.006297 0.00000 SCALE2 0.000000 0.012561 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012595 0.00000 MTRIX1 1 -1.000000 -0.002240 -0.002100 0.19615 1 MTRIX2 1 0.002250 -1.000000 -0.001590 83.07156 1 MTRIX3 1 -0.002100 -0.001590 1.000000 0.07188 1